Joon Lee
Stock Analyst at UBS
(4.97)
# 87
Out of 5,078 analysts
532
Total ratings
57.1%
Success rate
34.6%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Joon Lee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ALNY Alnylam Pharmaceuticals | Initiated Coverage: Buy | $354 | $224.03 | +58.01% | 1 | Oct 16, 2026 | |
| ASND Ascendis Pharma | Initiated Coverage: Buy | $269 | $243.37 | +10.53% | 1 | Oct 16, 2026 | |
| BBIO BridgeBio Pharma | Initiated Coverage: Buy | $92 | $68.56 | +34.19% | 1 | Oct 16, 2026 | |
| IONS Ionis Pharmaceuticals | Initiated Coverage: Buy | $88 | $42.93 | +104.98% | 1 | Oct 16, 2026 | |
| PTCT PTC Therapeutics | Initiated Coverage: Buy | $90 | $60.59 | +48.54% | 12 | Oct 16, 2026 | |
| REGN Regeneron Pharmaceuticals | Initiated Coverage: Buy | $978 | $805.02 | +21.49% | 1 | Oct 16, 2026 | |
| ARWR Arrowhead Pharmaceuticals | Rated: Buy | $109 | $58.02 | +87.87% | 1 | Oct 15, 2026 | |
| BMRN BioMarin Pharmaceutical | Rated: Buy | $88 | $55.95 | +57.28% | 15 | Oct 15, 2026 | |
| CRSP CRISPR Therapeutics AG | Initiated Coverage: Hold | $52 | $49.39 | +5.28% | 25 | Oct 15, 2026 | |
| PRAX Praxis Precision Medicines | Initiated Coverage: Buy | $700 → $706 | $252.96 | +179.10% | 30 | Oct 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $76 → $48 | $22.43 | +114.00% | 2 | Oct 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $76 → $16 | $15.65 | +2.24% | 30 | Oct 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $20 | $5.92 | +237.84% | 12 | Oct 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $94 | $24.40 | +285.25% | 44 | Oct 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $11 | $3.18 | +245.91% | 42 | Oct 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $2.40 | - | 22 | Mar 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $1.74 | - | 16 | Mar 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $525 | $523.93 | +0.20% | 16 | Mar 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $50 | $48.73 | +2.61% | 30 | Mar 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $85.86 | - | 38 | Mar 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $11.21 | - | 29 | Mar 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $43.63 | - | 3 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $214.00 | - | 26 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $145.04 | - | 37 | Feb 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $25.93 | - | 2 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $2.35 | - | 8 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $3.96 | - | 24 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $873.71 | n/a | 38 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $11.28 | n/a | 1 | Dec 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 | $7.85 | n/a | 10 | Nov 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $100 → $65 | $7.30 | n/a | 5 | Jan 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $7 → $4 | $3.27 | n/a | 4 | Dec 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $12.80 | n/a | 1 | Aug 8, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $20 | $4.40 | n/a | 1 | Jun 19, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $17.73 | n/a | 1 | Aug 8, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $33 | $19.73 | n/a | 1 | Aug 7, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 | $1.08 | n/a | 1 | Jul 28, 2014 |
Alnylam Pharmaceuticals
Oct 16, 2026
Initiated Coverage: Buy
Price Target: $354
Current: $224.03
Upside: +58.01%
Ascendis Pharma
Oct 16, 2026
Initiated Coverage: Buy
Price Target: $269
Current: $243.37
Upside: +10.53%
BridgeBio Pharma
Oct 16, 2026
Initiated Coverage: Buy
Price Target: $92
Current: $68.56
Upside: +34.19%
Ionis Pharmaceuticals
Oct 16, 2026
Initiated Coverage: Buy
Price Target: $88
Current: $42.93
Upside: +104.98%
PTC Therapeutics
Oct 16, 2026
Initiated Coverage: Buy
Price Target: $90
Current: $60.59
Upside: +48.54%
Regeneron Pharmaceuticals
Oct 16, 2026
Initiated Coverage: Buy
Price Target: $978
Current: $805.02
Upside: +21.49%
Arrowhead Pharmaceuticals
Oct 15, 2026
Rated: Buy
Price Target: $109
Current: $58.02
Upside: +87.87%
BioMarin Pharmaceutical
Oct 15, 2026
Rated: Buy
Price Target: $88
Current: $55.95
Upside: +57.28%
CRISPR Therapeutics AG
Oct 15, 2026
Initiated Coverage: Hold
Price Target: $52
Current: $49.39
Upside: +5.28%
Praxis Precision Medicines
Oct 15, 2026
Initiated Coverage: Buy
Price Target: $700 → $706
Current: $252.96
Upside: +179.10%
Oct 15, 2026
Reiterated: Buy
Price Target: $76 → $48
Current: $22.43
Upside: +114.00%
Oct 15, 2026
Initiated Coverage: Hold
Price Target: $76 → $16
Current: $15.65
Upside: +2.24%
Oct 15, 2026
Initiated Coverage: Buy
Price Target: $20
Current: $5.92
Upside: +237.84%
Oct 15, 2026
Initiated Coverage: Buy
Price Target: $94
Current: $24.40
Upside: +285.25%
Oct 15, 2026
Initiated Coverage: Buy
Price Target: $11
Current: $3.18
Upside: +245.91%
Mar 17, 2026
Reiterated: Hold
Price Target: n/a
Current: $2.40
Upside: -
Mar 17, 2026
Reiterated: Buy
Price Target: n/a
Current: $1.74
Upside: -
Mar 11, 2026
Reiterated: Buy
Price Target: $525
Current: $523.93
Upside: +0.20%
Mar 9, 2026
Reiterated: Hold
Price Target: $50
Current: $48.73
Upside: +2.61%
Mar 2, 2026
Reiterated: Buy
Price Target: n/a
Current: $85.86
Upside: -
Mar 2, 2026
Reiterated: Buy
Price Target: n/a
Current: $11.21
Upside: -
Feb 26, 2026
Reiterated: Buy
Price Target: n/a
Current: $43.63
Upside: -
Feb 25, 2026
Reiterated: Buy
Price Target: n/a
Current: $214.00
Upside: -
Feb 24, 2026
Reiterated: Buy
Price Target: n/a
Current: $145.04
Upside: -
Nov 10, 2025
Reiterated: Buy
Price Target: n/a
Current: $25.93
Upside: -
Nov 6, 2025
Reiterated: Buy
Price Target: n/a
Current: $2.35
Upside: -
Nov 5, 2025
Reiterated: Buy
Price Target: n/a
Current: $3.96
Upside: -
Aug 1, 2025
Reiterated: Buy
Price Target: n/a
Current: $873.71
Upside: n/a
Dec 4, 2024
Rated: Buy
Price Target: n/a
Current: $11.28
Upside: n/a
Nov 14, 2023
Reiterated: Buy
Price Target: $18
Current: $7.85
Upside: n/a
Jan 17, 2023
Reiterated: Buy
Price Target: $100 → $65
Current: $7.30
Upside: n/a
Dec 8, 2022
Reiterated: Hold
Price Target: $7 → $4
Current: $3.27
Upside: n/a
Aug 8, 2019
Reiterated: Buy
Price Target: $10
Current: $12.80
Upside: n/a
Jun 19, 2019
Initiated Coverage: Buy
Price Target: $20
Current: $4.40
Upside: n/a
Aug 8, 2014
Reiterated: Buy
Price Target: n/a
Current: $17.73
Upside: n/a
Aug 7, 2014
Reiterated: Buy
Price Target: $33
Current: $19.73
Upside: n/a
Jul 28, 2014
Reiterated: Buy
Price Target: $14
Current: $1.08
Upside: n/a